Amgen plans further $200M investment in new tech facility in Indianews2025-02-24T14:55:48+00:00February 24th, 2025|Endpoints News|
Sanofi, Teva bolster case for IBD drug with Phase 2 data, despite potential competitionnews2025-02-24T12:31:14+00:00February 24th, 2025|Endpoints News|
FDA approves first drug to treat ultra-rare lipid storage diseasenews2025-02-21T20:34:09+00:00February 21st, 2025|Endpoints News|
Pfizer ends rollout of Beqvez, putting another dent in hemophilia gene therapy fieldnews2025-02-21T12:24:53+00:00February 21st, 2025|Endpoints News|
Roche unveils plans for its DNA sequencer that’s been 18 years in the makingnews2025-02-20T19:27:24+00:00February 20th, 2025|Endpoints News|
In single case, spinal muscular atrophy drug given before birth spared baby of symptomsnews2025-02-20T16:18:49+00:00February 20th, 2025|Endpoints News|
Can amylin drugs take over from GLP-1s in obesity? Partnerless Zealand thinks sonews2025-02-20T11:30:29+00:00February 20th, 2025|Endpoints News|
Ascletis’ obesity pill looks similar to Roche’s drug, early data suggestnews2025-02-19T15:40:54+00:00February 19th, 2025|Endpoints News|
Biotech is still trying to make CRISPR a successnews2025-02-19T15:00:35+00:00February 19th, 2025|Endpoints News|
Supernus’ stock sinks after placebo effect derails mid-stage depression studynews2025-02-19T11:33:28+00:00February 19th, 2025|Endpoints News|
